Peripheral Artery Disease
PAD is a coronary risk equivalent that happens to present in the legs, and most patients die of myocardial infarction and stroke rather than losing a limb -which is why the statin and antiplatelet matter more than the revascularization. Two things are counterintuitive: supervised exercise therapy outperforms stenting for claudication, and a normal ABI does not exclude disease in a diabetic with calcified vessels.
🔍 Overview
The Framing That Changes Practice
PAD is atherosclerosis, and atherosclerosis is a systemic disease. A patient with PAD has roughly the cardiovascular risk of a patient with established coronary disease, and the leading causes of death are myocardial infarction and stroke, not limb loss. That single fact reorders the whole encounter: the highest-value interventions are the statin, the antiplatelet, blood pressure control and smoking cessation, not the angiogram.
The Spectrum
- Asymptomatic PAD -the largest group. Detected by ABI, and still carries the elevated cardiovascular risk that warrants medical therapy.
- Claudication -reproducible exertional muscle pain relieved by rest within minutes, in the muscle group one level below the diseased segment: buttock and hip pain with aortoiliac disease, calf pain with femoropopliteal disease.
- Atypical leg symptoms -more common than classic claudication, particularly in older patients and diabetics who limit their walking before symptoms appear.
- Chronic limb-threatening ischemia (CLTI) -rest pain, non-healing ulcers or gangrene. Rest pain is classically in the forefoot, worse lying flat, and relieved by hanging the leg over the side of the bed because gravity aids perfusion. This is a limb-at-risk diagnosis requiring urgent vascular referral.
- Acute limb ischemia -sudden onset with the six Ps, a separate emergency covered in its own topic.
Exam Findings
- Diminished or absent pulses, bruits, cool skin, hair loss, thickened nails, dependent rubor and elevation pallor, and prolonged capillary refill.
- Arterial ulcers -punched-out, painful, over pressure points and the toes, with a pale or necrotic base. Contrast with venous ulcers (medial malleolus, shallow, exudative, with hemosiderin staining and edema) and neuropathic ulcers (painless, over plantar pressure points, in diabetics).
- Examine the feet of every diabetic -the combination of neuropathy and PAD is what produces the diabetic foot infection pathway, and neuropathy silences the warning pain.
🧪 Diagnosis
Ankle-Brachial Index
- The ABI is the first-line test: the higher ankle systolic pressure (dorsalis pedis or posterior tibial) divided by the higher brachial pressure, measured with a Doppler probe.
- Interpretation: normal is roughly 1.00-1.40; 0.91-0.99 borderline; ≤ 0.90 diagnoses PAD; ≤ 0.40 indicates severe disease and correlates with rest pain and tissue loss.
- ⚠ An ABI above 1.40 is not a good result -it means noncompressible, calcified vessels, typical of diabetes and chronic kidney disease, and it renders the ABI uninterpretable. Use the toe-brachial index (digital arteries are usually spared from medial calcification; a TBI below about 0.70 is abnormal) or Doppler waveform analysis instead.
- Exercise ABI when resting ABI is normal or borderline but symptoms are typical -a post-exercise drop unmasks disease that a resting measurement misses.
- Anatomic imaging (duplex ultrasound, CT or MR angiography) is for planning revascularization, not for making the diagnosis. Ordering it before a revascularization decision has been made is a common low-value step.
Who to Test
- Exertional leg symptoms, non-healing wounds, or abnormal pulse exam -symptom-driven testing.
- Consider screening ABI in patients at meaningfully elevated risk: age 65 and over, or age 50 and over with diabetes or smoking history, or known atherosclerosis in another vascular bed -because a positive result changes medical therapy even when asymptomatic.
- Do not screen the general low-risk population -the USPSTF found insufficient evidence for routine ABI screening in asymptomatic adults without risk factors.
Differential
- Neurogenic claudication (spinal stenosis) -the key discriminator is what relieves it: vascular claudication is relieved by standing still, neurogenic claudication requires sitting or leaning forward. Patients with stenosis can cycle further than they can walk; the reverse is true in PAD.
- Venous claudication (bursting pain relieved by elevation), chronic compartment syndrome in younger athletes, arthritis, and radiculopathy.
🚨 Management
Treat the cardiovascular risk first, because that is what kills these patients. Every patient with PAD -including the asymptomatic ones- needs a high-intensity statin, single antiplatelet therapy, blood pressure control, glycemic management where relevant, and smoking cessation. This is the part of the visit most often skipped in favor of discussing the legs.
Medical Therapy
- Statin -high intensity, for every patient with PAD, which is a coronary risk equivalent. Statins reduce cardiovascular events and also improve walking distance and limb outcomes.
- Antiplatelet therapy -single agent (aspirin or clopidogrel) for symptomatic PAD. Dual antiplatelet therapy is not routine outside the post-revascularization setting.
- Low-dose rivaroxaban added to aspirin (COMPASS, 2017) reduces major adverse cardiovascular and limb events in selected higher-risk patients, at the cost of increased bleeding -a genuine trade-off requiring an individualized discussion rather than reflexive use.
- Smoking cessation is the single most important modifiable factor -it slows progression, reduces amputation and graft failure, and lowers cardiovascular events. Offer pharmacotherapy and behavioral support, not just advice.
- Blood pressure and diabetes control per standard targets. Beta-blockers are NOT contraindicated in PAD -this is a persistent myth; they do not worsen claudication meaningfully and should be used when otherwise indicated.
- Cilostazol improves walking distance in claudication (a phosphodiesterase-3 inhibitor with vasodilator and antiplatelet effects), but is contraindicated in heart failure, which is the reason to check before prescribing. Pentoxifylline is of minimal value.
Exercise Therapy (the counterintuitive centerpiece)
- Supervised exercise therapy is first-line for claudication and produces walking improvements comparable or superior to revascularization, with durable benefit and none of the procedural risk. It is underused because it is less immediately gratifying than a stent.
- The prescription is specific: walking to moderate claudication pain, resting until it resolves, repeating for roughly 30-45 minutes per session, at least three sessions a week, for a minimum of 12 weeks. Walking into the pain is the therapy, which is why patients need it explained rather than simply being told to exercise.
- Structured home-based programs help when supervised programs are unavailable, though with somewhat smaller effect.
Revascularization
- For claudication: reserved for lifestyle-limiting symptoms that persist despite exercise therapy and medical management -claudication is generally not limb-threatening, and most patients remain stable or improve, so the decision is about quality of life rather than salvage.
- For chronic limb-threatening ischemia: urgent vascular referral -rest pain, non-healing ulceration or gangrene means revascularization is limb-preserving, and delay costs limbs.
- Endovascular versus surgical bypass depends on lesion anatomy, conduit availability and patient risk; both remain in use.
- Wound care, offloading, infection control and podiatry are integral to CLTI outcomes -revascularization alone does not heal a wound that is being re-traumatized or infected.
🏥 Rounds
Pimp Questions
❓ A diabetic patient with classic claudication has an ABI of 1.5. What does that mean?
It does not mean he is fine -it means the ABI is uninterpretable. An ABI above 1.40 indicates noncompressible, medially calcified vessels, characteristic of diabetes and chronic kidney disease: the cuff cannot occlude a calcified artery, so the measured ankle pressure is falsely high and may mask severe disease. Use the toe-brachial index instead, because digital arteries are usually spared from medial calcification (TBI below about 0.70 is abnormal), or use Doppler waveform analysis. Treating a high ABI as reassurance in a symptomatic diabetic is a classic error.
❓ Why is supervised exercise therapy first-line for claudication rather than stenting?
Because it produces walking improvements comparable or superior to revascularization, with durable benefit and none of the procedural risk, restenosis or access complications. Claudication is generally not limb-threatening and most patients remain stable or improve, so the decision is about quality of life rather than salvage. The prescription is specific: walk to moderate claudication pain, rest until it resolves, repeat for 30-45 minutes, three or more times weekly, for at least 12 weeks. Walking INTO the pain is the therapy, which is why it must be explained rather than issued as generic exercise advice.
❓ How do you distinguish vascular from neurogenic claudication at the bedside?
By what relieves it and by posture. Vascular claudication is relieved by standing still -it is a supply-demand problem, so stopping the demand fixes it regardless of position. Neurogenic claudication (spinal stenosis) requires sitting or leaning forward, because flexion opens the spinal canal, which is why patients lean on a shopping cart and can cycle further than they can walk. In PAD the reverse holds, and walking uphill is worse (more demand), whereas uphill walking is easier in stenosis (more flexion). Pulses, hair loss and an abnormal ABI settle it.
❓ A patient with PAD needs a beta-blocker after myocardial infarction. Is it contraindicated?
No -this is a persistent myth. The theoretical concern was that beta-blockade would worsen claudication through unopposed alpha vasoconstriction, but beta-blockers do not meaningfully worsen claudication and should be prescribed when otherwise indicated. Withholding them costs the patient a proven mortality benefit in a population whose leading cause of death is myocardial infarction, not limb loss. The same framing applies throughout: PAD is a coronary risk equivalent, so the cardiovascular medications are the highest-value part of the plan.
❓ A patient reports foot pain at night relieved by hanging the leg out of bed. What is this and how urgent?
Ischemic rest pain -chronic limb-threatening ischemia, and it needs urgent vascular referral. The mechanism explains the sign: lying flat removes the gravitational assist to an already marginal arterial supply, so perfusion pressure falls below what the tissue needs, and dependency restores enough flow to relieve the pain. It is classically forefoot pain. Unlike claudication, which is about quality of life, CLTI is limb-threatening and revascularization is limb-preserving, so delay costs limbs. Look also for non-healing ulcers and gangrene, and check the ABI (often ≤ 0.40).
Sample Presentation
Mr. Sørensen is a 68-year-old man, 40 pack-year smoker with hypertension and type 2 diabetes, reporting right calf pain after walking about two blocks, relieved within minutes of stopping, progressive over a year. Exam: absent right dorsalis pedis, diminished posterior tibial, hair loss over the shin, no ulcers. Resting ABI on the right is 0.68. He is on metformin and lisinopril but no statin and no aspirin.
Key Points: (1) This is classic claudication with an ABI confirming PAD -and the most important omissions are not vascular procedures but the missing statin and antiplatelet. PAD is a coronary risk equivalent, and his likeliest cause of death is myocardial infarction or stroke, so high-intensity statin, single antiplatelet, BP and glycemic control, and smoking cessation with pharmacotherapy are the highest-value actions today. (2) Refer for supervised exercise therapy as first-line, explaining that walking into moderate pain is the treatment -30 to 45 minutes, three times weekly, for at least 12 weeks- and that this matches or beats stenting for walking distance. (3) Reserve revascularization for lifestyle-limiting symptoms that persist despite that, and note his diabetes: if the ABI had been above 1.40, it would have been uninterpretable and needed a toe-brachial index instead.
Clinic Checklist
- ABI measured for exertional leg symptoms, non-healing wounds or abnormal pulses.
- High ABI (> 1.40) recognized as uninterpretable -toe-brachial index in diabetics and CKD.
- Statin and antiplatelet started -the most commonly missed part of the visit.
- Smoking cessation offered with pharmacotherapy, not just advice.
- Supervised exercise therapy referred and explained, before considering revascularization for claudication.
- Rest pain, ulceration or gangrene triggers urgent vascular referral -CLTI is limb-threatening.
- Beta-blockers not withheld when otherwise indicated.
- Feet examined and podiatry arranged in diabetics -neuropathy plus PAD is the amputation pathway.
📋 Summary
Summary
PAD Is a Coronary Risk Equivalent
Most patients with PAD die of myocardial infarction and stroke, not limb loss, which reorders the entire encounter: the statin, antiplatelet, blood pressure control and smoking cessation matter more than the angiogram. Even asymptomatic PAD found on screening warrants full medical therapy. This is the part of the visit most often skipped in favor of discussing the legs.
The ABI, and When It Lies
≤ 0.90 diagnoses PAD; ≤ 0.40 is severe disease. An ABI above 1.40 is not reassurance -it means noncompressible calcified vessels in diabetes or CKD, making the test uninterpretable. Use the toe-brachial index (digital arteries are spared from medial calcification; abnormal below ~0.70). Exercise ABI unmasks disease when the resting value is normal but symptoms are typical.
Exercise Beats Stenting for Claudication
Supervised exercise therapy produces walking improvement comparable or superior to revascularization, durably and without procedural risk. The prescription is specific: walk to moderate claudication pain, rest until it resolves, 30-45 minutes, 3+ times weekly, for at least 12 weeks. Walking into the pain is the therapy, so it must be explained rather than issued as generic advice.
Vascular vs Neurogenic Claudication
Vascular claudication is relieved by standing still (demand problem). Neurogenic claudication requires sitting or leaning forward, because flexion opens the canal -hence the shopping-cart sign and the ability to cycle further than walk. Uphill walking is worse in PAD (more demand) and easier in stenosis (more flexion). Pulses, hair loss and the ABI settle it.
Recognize Limb-Threatening Disease
Rest pain, non-healing ulcers or gangrene = chronic limb-threatening ischemia = urgent vascular referral. Classic rest pain is forefoot, worse lying flat and relieved by hanging the leg over the bed, because dependency restores gravitational perfusion to a marginal supply. Unlike claudication, this is limb-threatening and revascularization is limb-preserving, so delay costs limbs.
Know the Ulcers Apart
Arterial: punched-out, painful, over pressure points and toes, pale or necrotic base. Venous: medial malleolus, shallow, exudative, hemosiderin staining and edema. Neuropathic: painless, over plantar pressure points, in diabetics. Neuropathy plus PAD is the amputation pathway, because the neuropathy silences the warning pain -so examine every diabetic foot.
Two Prescribing Points
Beta-blockers are NOT contraindicated in PAD -a persistent myth that costs patients a proven mortality benefit in a population whose leading cause of death is cardiac. Cilostazol improves walking distance but is contraindicated in heart failure, so check before prescribing; pentoxifylline is of minimal value. Dual antiplatelet therapy is not routine outside post-revascularization.
Image to Plan, Not to Diagnose
The ABI makes the diagnosis; duplex, CT and MR angiography exist to plan revascularization, so ordering anatomic imaging before a revascularization decision has been made is a common low-value step. For claudication, revascularization is reserved for lifestyle-limiting symptoms persisting despite exercise and medical therapy; for CLTI it is urgent, and must be paired with wound care, offloading, infection control and podiatry, since revascularization alone will not heal a re-traumatized or infected wound.
